Free Trial

TerrAscend Q1 2024 Earnings Report

TerrAscend logo
$0.53 -0.01 (-2.58%)
As of 02/21/2025 03:51 PM Eastern

TerrAscend EPS Results

Actual EPS
-$0.06
Consensus EPS
-$0.03
Beat/Miss
Missed by -$0.03
One Year Ago EPS
N/A

TerrAscend Revenue Results

Actual Revenue
$80.63 million
Expected Revenue
$81.44 million
Beat/Miss
Missed by -$810.00 thousand
YoY Revenue Growth
N/A

TerrAscend Announcement Details

Quarter
Q1 2024
Time
N/A

Conference Call Resources

TerrAscend Earnings Headlines

TerrAscend reports preliminary Q4 revenue $74.4M vs. $74.2M last quarter
Elon Takes Aim at Social Security
Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social Security, finding what he says is widespread fraud across the agency.
See More TerrAscend Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like TerrAscend? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TerrAscend and other key companies, straight to your email.

About TerrAscend

TerrAscend (OTCMKTS:TSNDF) cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

View TerrAscend Profile

More Earnings Resources from MarketBeat